Karsten Wellner, CEO at Ascendis Health, speaks to Business Day TV about the company’s first-half results. BUSINESS DAY TV: Ascendis Health has reported a 34% jump in first-half normalised headline earnings per share (HEPS) and lifted its dividend by 16%. In addition, the pharmaceuticals group has announced its latest pair of acquisitions. These include Cyprus-based NHP Natural Health Pharma Limited and Rumania Sunwave Pharma SRL, as well. Ascendis CEO Karsten Wellner joins us now in the News Leader studio. Karsten … so some investors are pretty worried that after all the gobbling you’re doing, you’re going to be suffering soon from a whole lot of indigestion. Are you taking on way too much too quickly? KARSTEN WELLNER: No I don’t think so. Last year in August we bought two big companies, one a pharmaceutical company based in Cyprus and the other one was a sports nutrition business based in Hungary, and we actually started integrating these businesses and the integration was a real ...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.